当前位置: X-MOL 学术Inflamm. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MiR-802 alleviates lipopolysaccharide-induced acute lung injury by targeting Peli2.
Inflammation Research ( IF 6.7 ) Pub Date : 2019-11-06 , DOI: 10.1007/s00011-019-01295-z
Qinghai You 1 , Jinmei Wang 2 , Dan Jia 3 , Lijuan Jiang 4 , Yuanmin Chang 5 , Wenmei Li 5
Affiliation  

INTRODUCTION Acute respiratory distress syndrome (ARDS) is a life-threatening medical condition. It is characterized by serious lung inflammation or injury. Characterizing novel miRNAs implicated in ARDS pathogenesis may provide new therapeutic strategy for managing ARDS. METHODS We employed LPS-induced lung injury model to profile miRNAs associated with ARDS. We isolated one miRNA candidate and characterized its role in lipopolysaccharide (LPS)-induced proinflammatory cytokine production in lung macrophages. We further evaluated its functional role in ARDS model by assessing histological change, neutrophil activation, tissue permeability and tumor necrosis factor alpha (TNFα) production. We also characterized its downstream target using luciferase assay, Western blotting, enzyme-linked immunosorbent assay and cell inflammation assay. RESULTS Microarray profiling revealed miR-802 was significantly downregulated in ARDS mouse model. LPS-induced miR-802 downregulation was confirmed in lung macrophages. Overexpression of miR-802 significantly suppressed LPS-induced inflammatory cytokine production in vitro and alleviates LPS-induced acute lung injury in vivo. Peli2 was identified as a downstream target of miR-802 and found upregulated in ARDS model. Overexpressing Peli2 abolished the antagonizing effect of miR-802 on LPS-mediated inflammatory response. CONCLUSION MiR-802 carried a protective role against LPS-induced acute lung injury by downregulating Peli2. MiR-802/Peli2 axis may act as intervening targets to manage ARDS.

中文翻译:

MiR-802 通过靶向 Peli2 减轻脂多糖诱导的急性肺损伤。

简介 急性呼吸窘迫综合征 (ARDS) 是一种危及生命的疾病。它的特点是严重的肺部炎症或损伤。表征与 ARDS 发病机制有关的新 miRNA 可能为管理 ARDS 提供新的治疗策略。方法 我们采用 LPS 诱导的肺损伤模型来分析与 ARDS 相关的 miRNA。我们分离了一种 miRNA 候选物,并描述了其在肺巨噬细胞中脂多糖 (LPS) 诱导的促炎细胞因子产生中的作用。我们通过评估组织学变化、中性粒细胞活化、组织通透性和肿瘤坏死因子 α (TNFα) 产生进一步评估了其在 ARDS 模型中的功能作用。我们还使用荧光素酶测定、蛋白质印迹、酶联免疫吸附测定和细胞炎症测定对其下游靶标进行了表征。结果 微阵列分析显示 miR-802 在 ARDS 小鼠模型中显着下调。在肺巨噬细胞中证实了 LPS 诱导的 miR-802 下调。miR-802 的过表达在体外显着抑制 LPS 诱导的炎性细胞因子产生,并在体内减轻 LPS 诱导的急性肺损伤。Peli2 被确定为 miR-802 的下游靶标,并在 ARDS 模型中上调。过表达 Peli2 消除了 miR-802 对 LPS 介导的炎症反应的拮抗作用。结论 MiR-802 通过下调 Peli2 对 LPS 诱导的急性肺损伤具有保护作用。MiR-802/Peli2 轴可以作为干预目标来管理 ARDS。miR-802 的过表达在体外显着抑制 LPS 诱导的炎性细胞因子产生,并在体内减轻 LPS 诱导的急性肺损伤。Peli2 被确定为 miR-802 的下游靶标,并在 ARDS 模型中上调。过表达 Peli2 消除了 miR-802 对 LPS 介导的炎症反应的拮抗作用。结论 MiR-802 通过下调 Peli2 对 LPS 诱导的急性肺损伤具有保护作用。MiR-802/Peli2 轴可以作为干预目标来管理 ARDS。miR-802 的过表达在体外显着抑制 LPS 诱导的炎性细胞因子产生,并在体内减轻 LPS 诱导的急性肺损伤。Peli2 被确定为 miR-802 的下游靶标,并在 ARDS 模型中上调。过表达 Peli2 消除了 miR-802 对 LPS 介导的炎症反应的拮抗作用。结论 MiR-802 通过下调 Peli2 对 LPS 诱导的急性肺损伤具有保护作用。MiR-802/Peli2 轴可以作为干预目标来管理 ARDS。过表达 Peli2 消除了 miR-802 对 LPS 介导的炎症反应的拮抗作用。结论 MiR-802 通过下调 Peli2 对 LPS 诱导的急性肺损伤具有保护作用。MiR-802/Peli2 轴可以作为干预目标来管理 ARDS。过表达 Peli2 消除了 miR-802 对 LPS 介导的炎症反应的拮抗作用。结论 MiR-802 通过下调 Peli2 对 LPS 诱导的急性肺损伤具有保护作用。MiR-802/Peli2 轴可以作为干预目标来管理 ARDS。
更新日期:2019-11-01
down
wechat
bug